Orphan Drugs

Orphan pharmaceuticals are prescription medications used to treat rare illnesses or disorders that are meant to be treated, prevented from occurring, or diagnosed. They are referred to as "orphan medications" due to the small size of their market. A illness is considered an orphan if it affects fewer than 200,000 persons nationally. The majority of orphan diseases have a genetic basis. Orphan diseases are rare and could impact one in every 15 people worldwide.

 

    Related Conference of Orphan Drugs

    April 14-15, 2025

    15th European Epidemiology and Public Health Congress

    Budapest, Hungary
    June 02-03, 2025

    14th World Congress on Rare Diseases and Orphan Drugs

    Amsterdam, Netherlands
    June 02-03, 2025

    17th Euro-Global Conference on Infectious Diseases

    Amsterdam, Netherlands
    August 28-29, 2025

    8th Pathology and Infectious Disease Conference

    London, UK
    September 22-23, 2025

    11th International Conference on Infectious and Rare Diseases

    Vancouver, Canada
    December 11-12, 2025

    8th Annual Congress on Bacterial, Viral and Infectious Diseases

    Prague, Czech Republic

    Orphan Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in